Evidence map›Paper›PMID 40332740›Full record

ArticleObesity surgery2025

First-in-Human Linear Magnetic Jejuno-Ileal Bipartition: Preliminary Results with Incisionless, Sutureless, Swallowable Technique.

Michel Gagner, Martin Fried, David Michalsky, Karen Dolezalova, Petra Sramkova, Jan Brezina, Dasa Baliarova, Lucie Hlavata, Michal Novak, Jaroslav Bartos and 1 more

Abstract read
In one paragraph

Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michel GagnerWestmount Square Surgical Center, Westmount, Canada. gagner.michel@gmail.com.
Martin FriedOB Klinika, Prague, Czech Republic.
David MichalskyOB Klinika, Prague, Czech Republic.
Karen DolezalovaOB Klinika, Prague, Czech Republic.
Petra SramkovaOB Klinika, Prague, Czech Republic.
Jan BrezinaOB Klinika, Prague, Czech Republic.
Dasa BaliarovaCharles University, Prague, Czech Republic.
Lucie HlavataOB Klinika, Prague, Czech Republic.
Michal NovakOB Klinika, Prague, Czech Republic.
Jaroslav BartosOB Klinika, Prague, Czech Republic.
Sarka MullerovaOB Klinika, Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMinimally invasive surgery may be further advanced with the novel biofragmentable magnetic anastomosis compression system. Two magnets may be swallowed, or placed by flexible endoscopy, in a side-to-side magnetic jejuno-ileostomy (MagJI) bipartition for weight and type 2 diabetes (T2D) reduction. MagJI markedly reduces the major complications of enterotomy, stapling/suturing, and retained foreign materials.

methodsThis was a prospective first-in-human investigation of feasibility, safety, and preliminary efficacy in adults with body mass index (BMI, kg/m PRIMARY ENDPOINTS: feasibility and severe adverse event (SAEs) incidence (Clavien-Dindo grade); secondary endpoints: weight, T2D reduction.

resultsBetween 3-1 - 2024 and 6-30 - 2024, nine patients (mean BMI 37.3 ± 1.1) with T2D (all on T2D medications; mean HbA1

conclusionsThe swallowable, biofragmentable magnetic anastomosis system appeared to be feasible and safe in achieving incisionless, sutureless jejuno-ileostomy. The first-in-human MagJI procedure may offer minimally complicated anastomosis creation and moderate MBS weight loss and T2D reduction.

Indexed as

Diabetes Mellitus, Type 2IleumJejunostomyJejunumMagnetsAdultAnastomosis, SurgicalBody Mass IndexFeasibility StudiesFemaleHumansLaparoscopyMagneticsMaleMiddle AgedProspective StudiesBiofragmentableFirst-in-humanJejuno-ileostomyMagnetic compression anastomosisMetabolic/bariatric surgeryObesitySwallowableT2DType 2 diabetes

Identifiers

PMID40332740
PMCPMC12130062

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.